Joint Filing AgreementJoint Filing Agreement • February 14th, 2006 • Maverick Capital LTD • Biological products, (no disgnostic substances)
The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock, $0.001 par value of Onxy Pharmaceuticals, Inc., dated as of February 14, 2005, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
